Carmen Bozic reports Common stock sales on Form 144

Carmen R. Bozic reported sales of Common stock via Form 144.

Rhea-AI Filing Summary

Carmen R. Bozic reported sales of Common stock via Form 144. The filing lists sales dated 02/27/2026 and 03/13/2026 tied to the instrument identifier 2329. The excerpt also shows Restricted Stock Vesting entries dated 02/24/2025 (1687) and 02/26/2025 (642) labeled as compensation.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions does VRTX's Form 144 show?

The Form 144 shows reported sales of Common stock by Carmen R. Bozic on 02/27/2026 and 03/13/2026. The entries reference identifier 2329 and list two prior restricted stock vesting events in 2025.

How many restricted shares vested according to the filing for VRTX?

The excerpt lists restricted stock vesting of 1687 shares on 02/24/2025 and 642 shares on 02/26/2025, each labeled as compensation in the filing.

Who is the reporting person on the VRTX Form 144?

The reporting person named in the excerpt is Carmen R. Bozic with an address at 50 Northern Avenue, Boston, MA. The Form 144 entries reference Common stock transactions and associated dates.

Does the filing state proceeds or dollar amounts for the sales?

The excerpt includes numeric values 1118641.99 and 1122088.91 alongside the sale dates, but it does not label them explicitly as proceeds or specify currency within the provided excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/27/2026 - 10:32 AM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001790029
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	VERTEX PHARMACEUTICALS INC / MA
SEC File Number	000-19319
Address of Issuer	50 NORTHERN AVENUE BOSTON MASSACHUSETTS 02210
Phone	6173416393
Name of Person for Whose Account the Securities are To Be Sold	Bozic Carmen
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2329	1050262.55	254034190	03/27/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/24/2025	Restricted Stock Vesting	Issuer			1687	02/24/2025	Compensation
Common	02/26/2025	Restricted Stock Vesting	Issuer			642	02/26/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Carmen R. Bozic 50 Northern Avenue Boston MA 02210	Common	02/27/2026	2329	1118641.99
Carmen R. Bozic 50 Northern Avenue Boston MA 02210	Common	03/13/2026	2329	1122088.91

144: Remarks and Signature

Remarks
Date of Notice	03/27/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/20/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Carmen R. Bozic
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)